(Q33917563)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10809339%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

Gender-based differences and menstrual cycle-related changes in specific diseases: implications for pharmacotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10809339%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10809339%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Ensom MH

series ordinal

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10809339%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10809339%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10809339%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10809339%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

523-539

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10809339%20AND%20SRC:MED&resulttype=core&format=json

Gender and health: an update on hypotheses and evidence

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Illness and the feminine role: A theoretical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Another look at sex differences in the use of medical care: illness orientation and the types of morbidities for which services are used

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

HIV/AIDS patients' perspectives on adhering to regimens containing protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Cardiac rehabilitation: gender differences in factors influencing participation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Compliance with doxycycline therapy in sexually transmitted diseases clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Attendance at an asthma educational intervention: characteristics of participants and non-participants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Predicting compliance with annual follow-up evaluations in persons with spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Risk factors associated with women's compliance with estrogen replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Risk factors for antihypertensive medication refill failure by patients under Medicaid managed care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Compliance with supportive periodontal therapy and its relation to the bleeding index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychologic correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Characteristics of patients with asthma within a large HMO: a comparison by age and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Diminished incidence of severe rheumatoid arthritis associated with oral contraceptive use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Blindness due to diabetes: population-based age- and sex-specific incidence rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Sex differences in recurrent depression: are there any that are significant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Plasma Levels of Imipramine and Desmethylimipramine during Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Plasma nortriptyline and clinical response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Clomipramine metabolism. Model-based analysis of variability factors from drug monitoring data

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

First-pass metabolism of imipramine in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Forms of atypical depression and their response to antidepressant drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Epilepsy, sex hormones, and antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Reproductive endocrine considerations and hormonal therapy for women with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Management issues for women with epilepsy: a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Maximizing the health of women with epilepsy: science and ethics in new drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Effects of the menstrual cycle on medical disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Do exogenous oestrogens and progesterone influence asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

How common is catamenial epilepsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Premenstrual exacerbation of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

The effect of the menstrual cycle on asthma presentations in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

The effect of sodium meclofenamate in premenstrual asthma: a controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Effect of steroids on β-adrenoceptor-mediated relaxation of pig bronchus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Severe acute asthma and the menstrual cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Premenstrual symptoms in women with premenstrual asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Paradoxical down-regulation and desensitization of beta2-adrenoceptors by exogenous progesterone in female asthmatics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Modulation of airway reactivity and peak flow variability in asthmatics receiving the oral contraceptive pill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Loss of normal cyclical beta 2 adrenoceptor regulation and increased premenstrual responsiveness to adenosine monophosphate in stable female asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Estrogens and the hypothalamo-pituitary-adrenal axis in man: evidence for normal feedback regulation by corticosteroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

A pilot study of estrogen's effects on bronchial myocyte adhesion molecule expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Menstrual cyclicity of finger joint size and grip strength in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytic epidemiological studies using meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Estrogens, progestins, and headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Treatment of menstrual migraine by oestradiol implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Sumatriptan is effective in the treatment of menstrual migraine: a review of prospective studies and retrospective analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Perimenstrual symptoms in women with diabetes mellitus and the relationship to diabetic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Influence of the menstrual cycle on glucose tolerance and insulin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Effects of oral contraceptive agents on carbohydrate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Catamenial insulin reactions treated with a long-acting gonadotropin releasing hormone agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

The menstrual cycle and mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Three patterns of catamenial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Women's issues in epilepsy. Menses, childbearing, and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Ovarian hormones, anticonvulsant drugs, and seizures during the menstrual cycle in women with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Treatment of seizures with medroxyprogesterone acetate: preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Sex differences in unipolar depression: evidence and theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Effects of menstruation and pregnancy on epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161

Epidemiology of the rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.6.523.35161